WO2012155134A3 - Assay reagents for a neurogranin diagnostic kit - Google Patents
Assay reagents for a neurogranin diagnostic kit Download PDFInfo
- Publication number
- WO2012155134A3 WO2012155134A3 PCT/US2012/037774 US2012037774W WO2012155134A3 WO 2012155134 A3 WO2012155134 A3 WO 2012155134A3 US 2012037774 W US2012037774 W US 2012037774W WO 2012155134 A3 WO2012155134 A3 WO 2012155134A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- neurogranin
- assay reagents
- present
- diagnostic kit
- provides
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Plant Pathology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to the field of biomarkers. More specifically, the present invention relates to assay reagents useful in detecting neurogranin. In a specific embodiment, the present invention provides an isolated antibody or fragment thereof that specifically binds to neurogranin. In another embodiment, the present invention provides a polynucleotide aptamer that specifically binds neurogranin.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014510535A JP2014518624A (en) | 2011-05-12 | 2012-05-14 | Assay reagent for neurogranin diagnostic kit |
EP12782967.9A EP2707389B1 (en) | 2011-05-12 | 2012-05-14 | Assay reagents for a neurogranin diagnostic kit |
US14/117,111 US20140141458A1 (en) | 2011-05-12 | 2012-05-14 | Assay reagents for a neurogranin diagnostic kit |
US15/280,780 US9709578B2 (en) | 2011-05-12 | 2016-09-29 | Assay reagents for a neurogranin diagnostic kit |
US15/639,210 US10215764B2 (en) | 2011-05-12 | 2017-06-30 | Assay reagents for a neurogranin diagnostic kit |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161485375P | 2011-05-12 | 2011-05-12 | |
US61/485,375 | 2011-05-12 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/117,111 A-371-Of-International US20140141458A1 (en) | 2011-05-12 | 2012-05-14 | Assay reagents for a neurogranin diagnostic kit |
US15/280,780 Continuation US9709578B2 (en) | 2011-05-12 | 2016-09-29 | Assay reagents for a neurogranin diagnostic kit |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012155134A2 WO2012155134A2 (en) | 2012-11-15 |
WO2012155134A3 true WO2012155134A3 (en) | 2013-06-13 |
Family
ID=47140053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/037774 WO2012155134A2 (en) | 2011-05-12 | 2012-05-14 | Assay reagents for a neurogranin diagnostic kit |
Country Status (4)
Country | Link |
---|---|
US (3) | US20140141458A1 (en) |
EP (1) | EP2707389B1 (en) |
JP (1) | JP2014518624A (en) |
WO (1) | WO2012155134A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012051519A2 (en) * | 2010-10-14 | 2012-04-19 | The Johns Hopkins University | Biomarkers of brain injury |
EP2707389B1 (en) | 2011-05-12 | 2019-10-30 | The Johns Hopkins University | Assay reagents for a neurogranin diagnostic kit |
EP2825893A4 (en) | 2012-03-13 | 2016-03-16 | Univ Johns Hopkins | Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration |
US20160130585A1 (en) | 2013-05-28 | 2016-05-12 | The Johns Hopkins University | Aptamers for the treatment of sickle cell disease |
US10534003B2 (en) | 2013-07-17 | 2020-01-14 | The Johns Hopkins University | Multi-protein biomarker assay for brain injury detection and outcome |
FR3025317B1 (en) * | 2014-08-26 | 2022-09-23 | Imabiotech | METHOD FOR CHARACTERIZING A SAMPLE BY MASS SPECTROMETRY IMAGING |
EP3242134A1 (en) | 2016-05-04 | 2017-11-08 | Euroimmun Medizinische Labordiagnostika AG | Assay for the diagnosis of a neurological disease |
EP3630804A4 (en) * | 2017-05-23 | 2021-06-16 | Brainbox Solutions, Inc. | Biomarker levels and neuroimaging for detecting, monitoring and treating brain injury or trauma |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009143519A2 (en) * | 2008-05-23 | 2009-11-26 | The Johns Hopkins University | Biomarkers for myocardial ischemia |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
SE462454B (en) | 1988-11-10 | 1990-06-25 | Pharmacia Ab | METHOD FOR USE IN BIOSENSORS |
US5567588A (en) | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
US5475096A (en) | 1990-06-11 | 1995-12-12 | University Research Corporation | Nucleic acid ligands |
US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
US5707796A (en) | 1990-06-11 | 1998-01-13 | Nexstar Pharmaceuticals, Inc. | Method for selecting nucleic acids on the basis of structure |
US5683867A (en) | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
US5637459A (en) | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
DE69127627T2 (en) | 1990-08-29 | 1998-02-19 | Genpharm Int | Production and Use Non-human transgene heterologous antibodies for production |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
ES2113940T3 (en) | 1990-12-03 | 1998-05-16 | Genentech Inc | ENRICHMENT METHOD FOR PROTEIN VARIANTS WITH ALTERED UNION PROPERTIES. |
ES2201077T3 (en) | 1993-05-28 | 2004-03-16 | Baylor College Of Medicine | METHOD AND SPECTROMETER OF MASSES FOR DESORTION AND IONIZATION OF ANALYTS. |
US5866434A (en) | 1994-12-08 | 1999-02-02 | Meso Scale Technology | Graphitic nanotubes in luminescence assays |
US6673533B1 (en) | 1995-03-10 | 2004-01-06 | Meso Scale Technologies, Llc. | Multi-array multi-specific electrochemiluminescence testing |
US6140045A (en) | 1995-03-10 | 2000-10-31 | Meso Scale Technologies | Multi-array, multi-specific electrochemiluminescence testing |
BR9607193B1 (en) | 1995-03-10 | 2009-01-13 | multispecific multispecific electrochemical test. | |
US6207369B1 (en) | 1995-03-10 | 2001-03-27 | Meso Scale Technologies, Llc | Multi-array, multi-specific electrochemiluminescence testing |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
US6319670B1 (en) | 1995-05-09 | 2001-11-20 | Meso Scale Technology Llp | Methods and apparatus for improved luminescence assays using microparticles |
NZ516848A (en) | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
US6413783B1 (en) | 1997-09-18 | 2002-07-02 | Meso Scale Technologies, Llc | Assay sonication apparatus and methodology |
ATE340870T1 (en) | 1998-04-03 | 2006-10-15 | Compound Therapeutics Inc | ADDRESSABLE PROTEIN ARRAYS |
US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
US6780606B1 (en) | 1999-02-26 | 2004-08-24 | Synx Pharma, Inc. | Method for diagnosing and distinguishing stroke and diagnostic devices for use therein |
WO2000056934A1 (en) | 1999-03-24 | 2000-09-28 | Packard Bioscience Company | Continuous porous matrix arrays |
AU2001291217A1 (en) | 2000-09-22 | 2002-04-02 | University Of Aarhus | Novel compositions and methods for lymphoma and leukemia |
US7842246B2 (en) | 2001-06-29 | 2010-11-30 | Meso Scale Technologies, Llc | Assay plates, reader systems and methods for luminescence test measurements |
DE60236732D1 (en) | 2001-07-30 | 2010-07-29 | Meso Scale Technologies Llc | ASSAY ELECTRODES WITH REAL-ESTABLISHED LIPID / PROTEIN LAYERS AND PROCESS FOR THEIR PREPARATION AND USE |
JP2005522669A (en) | 2001-08-20 | 2005-07-28 | バイオサイト インコーポレイテッド | Diagnostic markers for stroke and brain injury and methods of use thereof |
EP1436598B1 (en) | 2001-09-10 | 2013-11-27 | Meso Scale Technologies LLC | Assay buffer, compositions containing the same, and methods of using the same |
WO2003023360A2 (en) | 2001-09-10 | 2003-03-20 | Meso Scale Technologies, Llc | Methods and apparatus for conducting multiple measurements on a sample |
US20070098728A1 (en) * | 2001-09-24 | 2007-05-03 | Pedersen Finn S | Novel compositions and methods in cancer |
AU2002352355B2 (en) | 2001-12-05 | 2008-04-03 | Sengenics Corporation Pte Ltd | Protein arrays for allelic variants and uses thereof |
US20040014143A1 (en) * | 2002-05-29 | 2004-01-22 | Haskins William E. | Method and apparatus for detecting and monitoring peptides, and peptides identified therewith |
US7036946B1 (en) | 2002-09-13 | 2006-05-02 | Rockwell Collins, Inc. | LCD backlight with UV light-emitting diodes and planar reactive element |
CA3171720C (en) | 2002-12-26 | 2024-01-09 | Meso Scale Technologies, Llc. | Methods for conducting electrochemiluminescence measurements |
US7981362B2 (en) | 2003-11-04 | 2011-07-19 | Meso Scale Technologies, Llc | Modular assay plates, reader systems and methods for test measurements |
US7396654B2 (en) | 2004-04-15 | 2008-07-08 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for traumatic brain injury |
DE602005013957D1 (en) | 2004-06-03 | 2009-05-28 | Meso Scale Technologies Llc | METHOD FOR PERFORMING FULL BLOOD TESTS |
JP5190261B2 (en) * | 2004-06-25 | 2013-04-24 | ワシントン・ユニバーシティ | Markers for brain injury |
US20060257943A1 (en) | 2005-01-25 | 2006-11-16 | Cis Biotech, Inc. | Ischemic biomarkers and their use to predict adverse neurological events from surgery |
US7884260B2 (en) | 2005-06-14 | 2011-02-08 | University Of Chicago | Cell-based screen for agents useful for reducing neuronal demyelination or promoting neuronal remyelination |
GB2428240A (en) | 2005-07-14 | 2007-01-24 | Univ Gen Ve | Diagnostic method for brain damage-related disorders |
US20080026485A1 (en) | 2006-04-18 | 2008-01-31 | Wolfgang Hueber | Antibody profiling for determination of patient responsiveness |
WO2007136617A2 (en) | 2006-05-18 | 2007-11-29 | Walter Reed Army Institute Of Research (Wrair) | Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury |
US8088584B2 (en) | 2006-10-16 | 2012-01-03 | Bayer Schering Pharma Aktiengesellschaft | LTBP2 as a biomarker and diagnostic target |
EP2015196A1 (en) | 2007-06-28 | 2009-01-14 | Siemens Aktiengesellschaft | Programmer interface for manufacturing execution system |
US20110143375A1 (en) | 2008-08-11 | 2011-06-16 | Banyan Blomakers, Inc. | Biomarker detection process and assay of neurological condition |
GB201008541D0 (en) | 2010-05-21 | 2010-07-07 | Univ Geneve | Diagnostic methods |
EP2707389B1 (en) | 2011-05-12 | 2019-10-30 | The Johns Hopkins University | Assay reagents for a neurogranin diagnostic kit |
-
2012
- 2012-05-14 EP EP12782967.9A patent/EP2707389B1/en active Active
- 2012-05-14 WO PCT/US2012/037774 patent/WO2012155134A2/en active Application Filing
- 2012-05-14 JP JP2014510535A patent/JP2014518624A/en active Pending
- 2012-05-14 US US14/117,111 patent/US20140141458A1/en not_active Abandoned
-
2016
- 2016-09-29 US US15/280,780 patent/US9709578B2/en active Active
-
2017
- 2017-06-30 US US15/639,210 patent/US10215764B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009143519A2 (en) * | 2008-05-23 | 2009-11-26 | The Johns Hopkins University | Biomarkers for myocardial ischemia |
Non-Patent Citations (3)
Title |
---|
DATABASE NCBI [online] 14 January 2011 (2011-01-14), XP003030202, Database accession no. NP_006167 * |
PAK, J. ET AL.: "Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic platicity, and spatial learning: a study with knockout mice", PROC. NATL. ACAD. SCI. USA, vol. 97, no. 21, 10 October 2000 (2000-10-10), pages 11232 - 11237, XP002250333 * |
TOK, J. ET AL.: "Single microbead SELEX for efficient ssDNA aptamer generation against botulinum neurotoxin", CHEM. COMMUN., 18 March 2008 (2008-03-18), pages 1883 - 1885, XP055071723 * |
Also Published As
Publication number | Publication date |
---|---|
US20170315138A1 (en) | 2017-11-02 |
JP2014518624A (en) | 2014-08-07 |
US20140141458A1 (en) | 2014-05-22 |
US9709578B2 (en) | 2017-07-18 |
EP2707389A2 (en) | 2014-03-19 |
WO2012155134A2 (en) | 2012-11-15 |
US10215764B2 (en) | 2019-02-26 |
EP2707389A4 (en) | 2015-08-12 |
EP2707389B1 (en) | 2019-10-30 |
US20170038397A1 (en) | 2017-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012155134A3 (en) | Assay reagents for a neurogranin diagnostic kit | |
WO2010118411A3 (en) | Improved methods for conducting assays | |
EP4219750A3 (en) | Improved methods for conducting multiplexed assays | |
EP4249605A3 (en) | Methods for analyte detection | |
GB201200658D0 (en) | Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence | |
MX340453B (en) | Biomarkers for lung cancer. | |
GB201118647D0 (en) | Transgenic non-human assay vertebrates, assays and kits | |
GB201014805D0 (en) | Microfluidics based assay device | |
PH12014502581A1 (en) | Aptamer-based mulitiplexed assays | |
WO2012021887A3 (en) | Biomarkers for the early detection of breast cancer | |
HUE036585T2 (en) | Multigene prognostic assay for lung cancer | |
PT2507635E (en) | Biochemical serum biomarker | |
WO2010096674A3 (en) | A+ biomarker assays | |
MX353954B (en) | Aptamers and diagnostic methods for detecting the egf receptor. | |
WO2012170206A3 (en) | Color-producing diagnostic systems, reagents and methods | |
WO2013115410A3 (en) | Anti-phospholipase d4 antibody | |
WO2013124738A3 (en) | Methods and biomarkers for detection and prognosis of cervical cancer | |
WO2013079981A3 (en) | Biomarker-based methods and biochips for aiding the diagnosis of stroke | |
WO2014151290A3 (en) | Assay for predictive biomarkers | |
MX2015004419A (en) | Detecting an analyte and determining the concentration of an analyte using magnetizable beads. | |
WO2011133450A3 (en) | Serology assays | |
WO2011130647A3 (en) | Compositions and methods for characterizing a myopathy | |
GB201119585D0 (en) | Assay | |
WO2013165969A3 (en) | Methods and kits for diagnosing heparin-induced thrombocytopenia | |
MX2014001224A (en) | Assay for detection of jc virus dna. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12782967 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2014510535 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012782967 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14117111 Country of ref document: US |